Popular Articles

Supply Shortages Of Cerezyme And Fabrazyme - Priority Access Forpatients Most In Need Of Treatment Recommended
The European Medicines Agency"s (EMEA) Committee for Medicinal Products

Statement By HHS Secretary Kathleen Sebelius And HHS Agencies On The Signing Of The Family Smoking Prevention And Tobacco Control Act
Today, President Obama took historic action to save lives, reduce health care costs, and help reduce suffering from heart and lung diseases, cancer, and other tobacco-related illnesses. These illnesses kill hundreds of thousands of Americans every year, and the new law gives us the tools to effectively address this major public health issue. This is a key step forward and an important part of health reform.
News of the day
Fungal Toxin Mystery Solved Using Biolog's Phenotype MicroArrayTM Technology
An important breakthrough in fungal toxin biology has been made possible through the use of Biolog"s Phenotype MicroArray technology. This major advance is described in two recent publications from a group at CSIRO in Queensland, Australia. The work by Donald Gardiner and his collaborators has recently been published in online editions of the journals Fungal Genetics and Biology and Microbiology.
Endocrinology

'World First' Shows Heart Can Recover, Says British Heart Foundation

In response to the publication of the story of heart transplant patient Hannah Clark in the Lancet , Professor Peter Weissberg, Medical Director of the British Heart Foundation (BHF), described the operation as "an exciting and important event". He said: "Cardiologists have long wondered whether a heart which is failing because of cardiomyopathy might be able to recover if rested. "This seems to be exactly what has happened in Hannah"s case in which the donor heart allowed her own heart to take a rest and recover. This is an exciting discovery since it proves that, in some instances, a weakened heart has the capacity to recover if it can be helped" "This breakthrough provides a great boost to ongoing efforts to perfect a mechanical heart, called a "ventricular assist device", that can be used temporarily to take over the work of a weak heart while it recovers. "This is a great example of how a pioneering and novel approach to a medical problem can lead to surprising results that tell us a lot about how some heart diseases progress. It also opens the way for new research on just how damaged hearts manage to recover, which in turn may lead to new treatments for heart failure." The British Heart Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):